MARSHALL WACE, LLP - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$156,609
-54.1%
69,296
-24.4%
0.00%
-100.0%
Q2 2022$341,000
-62.5%
91,670
-34.2%
0.00%
-50.0%
Q1 2022$909,000
+33.9%
139,386
+138.8%
0.00%
+100.0%
Q4 2021$679,00058,3580.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
View complete list of TAYSHA GENE THERAPIES INC shareholders